Treatment decision-making for localized prostate cancer: What younger men choose and why
Article first published online: 25 APR 2011
Copyright © 2011 Wiley Periodicals, Inc.
Volume 72, Issue 1, pages 58–64, January 2012
How to Cite
Sidana, A., Hernandez, D. J., Feng, Z., Partin, A. W., Trock, B. J., Saha, S. and Epstein, J. I. (2012), Treatment decision-making for localized prostate cancer: What younger men choose and why. Prostate, 72: 58–64. doi: 10.1002/pros.21406
- Issue published online: 24 NOV 2011
- Article first published online: 25 APR 2011
- Manuscript Accepted: 28 MAR 2011
- Manuscript Received: 25 JAN 2011
- information seeking;
- prostate cancer
BACKGROUND AND OBJECTIVE
The literature lacks knowledge about information preferences and decision-making in young prostate cancer patients. This study provides insight into information sources consulted and factors dictating treatment decision-making in young prostate cancer patients.
Subjects were identified from pathology consult service of a National Center of Excellence. Questionnaires were mailed to 986 men, under 50 years of age, diagnosed with Gleason score 6 prostate cancer between 2001 and 2005.
Four hundred ninety-three men responded. The most common primary therapies were surgery 397 (81.4%), radiation 52 (10.7%), and active surveillance (AS) 26 (5.3%). Participants with at least some college education (P = 0.003) or annual income >$100,000 (P = 0.003) were more likely to consult three or more doctors. Amongst all treatments, “doctor's recommendation” was the most influential information source, although relatively less important in the AS group. Internet was the second most frequent information source. Participants with higher education (P = 0.0003) and higher income (P = 0.002) considered sexual function more important while making a treatment choice. Only 2% of the men preferred a passive role in the decision-making. Informed decision-making was preferred more by patients who chose radiation and AS while shared decision-making was preferred more by surgery patients (P < 0.05). The majority (89%) of the respondents did not regret their decision. No difference in satisfaction levels was found between different treatment modalities.
This study provides insight into information sources consulted, such as the greater internet use, and various factors dictating treatment decision-making in young prostate cancer patients. There was an overall very high satisfaction rate regardless of the therapy chosen. Prostate 72:58–64, 2012. © 2011 Wiley Periodicals, Inc.